NCT02465918

Brief Summary

Motor cortex stimulation (MCS) is a form of brain stimulation for patients with neuropathic pain not responsive to medication. An electrode is placed on the surface of the brain and connected to a programmable battery in the chest. The strength of stimulation can be individually adjusted by changing the voltage of stimulation. A too high voltage will produce side effects (e.g. seizures) while a too low voltage will not provide pain control. The aim of this study is to analyze the optimal stimulation timing parameters in patients already implanted with MCS and have received good pain relief. The investigators wish to cyclize on/off MCS in order to save the battery life of the stimulator and also decrease stimulus habituation. The investigators hope to determine these timing parameters while maintaining optimal pain relief.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
6

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jul 2015

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 4, 2015

Completed
5 days until next milestone

First Posted

Study publicly available on registry

June 9, 2015

Completed
22 days until next milestone

Study Start

First participant enrolled

July 1, 2015

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2016

Completed
Last Updated

October 30, 2020

Status Verified

October 1, 2020

Enrollment Period

1 year

First QC Date

June 4, 2015

Last Update Submit

October 29, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in Pain measured on the Visual Analogue Scale (VAS) with different stimulation settings

    At the End of each trial period, typically 14 days after change in stimulation settings

Secondary Outcomes (1)

  • Quality of Life assessment with the SF-36 questionnaire

    At the end of each trial period, typically at 14 days after change in stimulation settings

Other Outcomes (1)

  • Pain assessment with the McGill pain questionnaire to record impact of pain

    At the end of each trial period, typically 14 days after change in stimulation setting

Study Arms (4)

Original Setting- MCS 30 min off/0 min off

ACTIVE COMPARATOR

Patients at baseline with their original MCS settings: on 30 minutes, off 0 minutes in any single half-hour.

Device: motor cortex stimulation (Change of Stimulation Timing)

MCS 25 min on/5 min off

EXPERIMENTAL

Patient MCS settings programmed to: on 25 minutes, off 5 minutes in any single half-hour.

Device: motor cortex stimulation (Change of Stimulation Timing)

MCS 20 min on/10 min off

EXPERIMENTAL

Patient MCS settings programmed to: on 20 minutes, off 10 minutes in any single half-hour.

Device: motor cortex stimulation (Change of Stimulation Timing)

MCS 15 min on/15 min off

EXPERIMENTAL

Patient MCS settings programmed to: on 15 minutes, off 15 minutes in any single hour.

Device: motor cortex stimulation (Change of Stimulation Timing)

Interventions

MCS 15 min on/15 min offMCS 20 min on/10 min offMCS 25 min on/5 min offOriginal Setting- MCS 30 min off/0 min off

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult patient more than 18 years of age
  • Chronic neuropathic pain effectively treated with motor cortex stimulation
  • Stable medication during the trial
  • Willing and able to comply with the study protocol and to return per the follow-up visit schedule and able to provide informed consent.

You may not qualify if:

  • Evidence of an active disruptive psychiatric disorder or other known condition significant enough to impact the perception of pain, compliance to intervention and/or ability to evaluate treatment outcome as determined by the investigator
  • Technical malfunction of the MCS device
  • History of seizures
  • Unable to provide informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Vancouver General Hospital

Vancouver, British Columbia, V5Z 4E3, Canada

Location

Related Publications (4)

  • Tsubokawa T, Katayama Y, Yamamoto T, Hirayama T, Koyama S. Treatment of thalamic pain by chronic motor cortex stimulation. Pacing Clin Electrophysiol. 1991 Jan;14(1):131-4. doi: 10.1111/j.1540-8159.1991.tb04058.x.

  • Tsubokawa T, Katayama Y, Yamamoto T, Hirayama T, Koyama S. Chronic motor cortex stimulation for the treatment of central pain. Acta Neurochir Suppl (Wien). 1991;52:137-9. doi: 10.1007/978-3-7091-9160-6_37.

  • Peyron R, Garcia-Larrea L, Deiber MP, Cinotti L, Convers P, Sindou M, Mauguiere F, Laurent B. Electrical stimulation of precentral cortical area in the treatment of central pain: electrophysiological and PET study. Pain. 1995 Sep;62(3):275-286. doi: 10.1016/0304-3959(94)00211-V.

  • Lima MC, Fregni F. Motor cortex stimulation for chronic pain: systematic review and meta-analysis of the literature. Neurology. 2008 Jun 10;70(24):2329-37. doi: 10.1212/01.wnl.0000314649.38527.93.

MeSH Terms

Conditions

Neuralgia

Condition Hierarchy (Ancestors)

Peripheral Nervous System DiseasesNeuromuscular DiseasesNervous System DiseasesPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor/Neurosurgeon

Study Record Dates

First Submitted

June 4, 2015

First Posted

June 9, 2015

Study Start

July 1, 2015

Primary Completion

July 1, 2016

Study Completion

July 1, 2016

Last Updated

October 30, 2020

Record last verified: 2020-10

Locations